Researchers update their analysis from the original Eight Americas study to reflect current life expectancy disparities in the United States.
AstraZeneca, Daiichi Sankyo claim PhIII lung cancer win for their next big ADC — but shares fall
AstraZeneca and Daiichi Sankyo’s multibillion-dollar antibody-drug conjugate alliance has generated a Phase III win, the partners say, beefing up the case that they have a